Serum Institute of India Seeks DCGI's Approval for Market Authorisation of Its COVID-19 ... - Latest Tweet by PTI News
The latest Tweet by PTI News states, 'Serum Institute of India seeks DCGI's approval for market authorisation of its COVID-19 vaccine Covovax as booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin: Official sources'
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)